QURE – uniQure N.V.
QURE — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
16.56
Margin Of Safety %
Put/Call OI Ratio
0.2
EPS Next Q Diff
0.42
EPS Last/This Y
0.02
EPS This/Next Y
0.84
Price
46.38
Target Price
68
Analyst Recom
1.36
Performance Q
92.22
Upside
-405.4%
Beta
0.93
Ticker: QURE
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-14 | QURE | 41.51 | 0.19 | 0.19 | 200498 |
| 2026-07-15 | QURE | 41.03 | 0.19 | 0.64 | 201681 |
| 2026-07-16 | QURE | 39.37 | 0.19 | 0.24 | 202549 |
| 2026-07-17 | QURE | 40.27 | 0.19 | 1.27 | 205746 |
| 2026-07-20 | QURE | 39.68 | 0.18 | 0.57 | 123257 |
| 2026-07-21 | QURE | 40.05 | 0.18 | 0.64 | 124454 |
| 2026-07-22 | QURE | 40.41 | 0.19 | 0.36 | 124961 |
| 2026-07-23 | QURE | 39.55 | 0.19 | 0.02 | 128088 |
| 2026-07-24 | QURE | 39 | 0.19 | 0.06 | 132677 |
| 2026-07-27 | QURE | 38.23 | 0.18 | 0.08 | 137635 |
| 2026-07-28 | QURE | 36.7 | 0.18 | 0.26 | 138615 |
| 2026-07-29 | QURE | 40.03 | 0.17 | 0.32 | 142685 |
| 2026-07-30 | QURE | 42.21 | 0.18 | 1.13 | 144488 |
| 2026-07-31 | QURE | 43.7 | 0.18 | 0.67 | 145147 |
| 2026-08-03 | QURE | 44.04 | 0.19 | 0.05 | 145648 |
| 2026-08-04 | QURE | 43.92 | 0.19 | 0.10 | 145968 |
| 2026-08-05 | QURE | 44.26 | 0.19 | 0.05 | 147890 |
| 2026-08-06 | QURE | 45.45 | 0.19 | 0.81 | 148592 |
| 2026-08-07 | QURE | 46.4 | 0.20 | 0.42 | 150746 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-14 | QURE | 41.51 | -18.8 | - | -3.16 |
| 2026-07-15 | QURE | 41.01 | -18.8 | - | -3.16 |
| 2026-07-16 | QURE | 39.33 | -18.8 | - | -3.16 |
| 2026-07-17 | QURE | 40.26 | -18.8 | - | -3.16 |
| 2026-07-20 | QURE | 39.70 | -18.8 | - | -3.16 |
| 2026-07-21 | QURE | 40.09 | -18.8 | - | -3.16 |
| 2026-07-22 | QURE | 40.39 | -18.8 | - | -3.16 |
| 2026-07-23 | QURE | 39.47 | -18.3 | - | -3.14 |
| 2026-07-24 | QURE | 38.99 | -18.3 | - | -3.14 |
| 2026-07-27 | QURE | 38.22 | -18.3 | - | -3.14 |
| 2026-07-28 | QURE | 36.71 | -18.3 | - | -3.14 |
| 2026-07-29 | QURE | 40.04 | -18.3 | - | -3.14 |
| 2026-07-30 | QURE | 42.23 | -18.3 | - | -3.14 |
| 2026-07-31 | QURE | 43.64 | -18.3 | - | -3.14 |
| 2026-08-03 | QURE | 44.03 | 33.7 | - | -3.37 |
| 2026-08-04 | QURE | 44.03 | 33.7 | - | -3.37 |
| 2026-08-05 | QURE | 44.32 | 30.5 | - | -3.48 |
| 2026-08-06 | QURE | 45.40 | 30.5 | - | -3.48 |
| 2026-08-07 | QURE | 46.38 | 31.0 | - | -3.44 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-14 | QURE | -7.85 | -3.79 | 18.73 |
| 2026-07-15 | QURE | -7.52 | -3.79 | 18.73 |
| 2026-07-16 | QURE | -7.52 | -3.79 | 18.73 |
| 2026-07-17 | QURE | -7.52 | -3.79 | 18.73 |
| 2026-07-20 | QURE | -7.52 | -4.10 | 18.73 |
| 2026-07-21 | QURE | -7.52 | -4.10 | 18.73 |
| 2026-07-22 | QURE | -7.52 | -4.10 | 18.73 |
| 2026-07-23 | QURE | -7.52 | -4.10 | 18.73 |
| 2026-07-24 | QURE | -7.52 | -4.10 | 18.73 |
| 2026-07-27 | QURE | -7.52 | -7.45 | 16.89 |
| 2026-07-28 | QURE | -7.52 | -7.45 | 16.89 |
| 2026-07-29 | QURE | -7.52 | -7.45 | 16.89 |
| 2026-07-30 | QURE | -7.52 | -7.45 | 16.89 |
| 2026-07-31 | QURE | -7.52 | -7.45 | 16.89 |
| 2026-08-03 | QURE | -7.38 | -7.49 | 16.56 |
| 2026-08-04 | QURE | -7.38 | -7.49 | 16.56 |
| 2026-08-05 | QURE | -7.38 | -7.49 | 16.56 |
| 2026-08-06 | QURE | -7.38 | -7.49 | 16.56 |
| 2026-08-07 | QURE | -7.38 | -7.49 | 16.56 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.22
Avg. EPS Est. Current Quarter
-0.82
Avg. EPS Est. Next Quarter
-0.8
Insider Transactions
-7.38
Institutional Transactions
-7.49
Beta
0.93
Average Sales Estimate Current Quarter
5
Average Sales Estimate Next Quarter
6
Fair Value
Quality Score
45
Growth Score
37
Sentiment Score
94
Actual DrawDown %
35.1
Max Drawdown 5-Year %
-90.1
Target Price
68
P/E
Forward P/E
PEG
P/S
172.47
P/B
9.93
P/Free Cash Flow
EPS
-4.05
Average EPS Est. Cur. Y
-3.44
EPS Next Y. (Est.)
-2.59
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1350.73
Relative Volume
0.87
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-89.1
EPS 1 7Days Diff
-0.3
EPS 1 30Days Diff
-0.28
EBIT Estimation
◆
QURE
Healthcare
$46.42
Swing / Pullback
Buy the dip on strong trends
WATCH
RSI
66.2
Range 1M
84.3%
Sup Dist
4.5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-13.2%
EPS NY
23.8%
52W%
59.5%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+46.5% upside
Upside
+46.5%
Quality
45
QURE — P/E HistoricalBiotechnology
uniQure N.V.Sector: Healthcare
Industry: Biotechnology
Employees: 221
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
QURE
Latest News
—
Caricamento notizie per QURE…
stock quote shares QURE – uniQure N.V. Stock Price stock today
news today QURE – uniQure N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QURE – uniQure N.V. yahoo finance google finance
stock history QURE – uniQure N.V. invest stock market
stock prices QURE premarket after hours
ticker QURE fair value insiders trading